APA (7th ed.) Citation

Beck, O., Burhenne, J., Fresnais, M., & Steimel, K. (2020). Safety and activity of the combination of ceritinib and dasatinib in osteosarcoma. Cancers, 12(4), . https://doi.org/10.3390/cancers12040793

Chicago Style (17th ed.) Citation

Beck, Olaf, Jürgen Burhenne, Margaux Fresnais, and Kevin Steimel. "Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma." Cancers 12, no. 4 (2020). https://doi.org/10.3390/cancers12040793.

MLA (9th ed.) Citation

Beck, Olaf, et al. "Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma." Cancers, vol. 12, no. 4, 2020, https://doi.org/10.3390/cancers12040793.